{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:05:10Z","timestamp":1788318310336,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870649"],"award-info":[{"award-number":["81870649"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1601226"],"award-info":[{"award-number":["U1601226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670897"],"award-info":[{"award-number":["81670897"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.intimp.2020.106737","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T12:17:11Z","timestamp":1593433031000},"page":"106737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitis"],"prefix":"10.1016","volume":"86","author":[{"given":"Yingqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenru","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0005","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/ACI.0000000000000204","article-title":"Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study","volume":"15","author":"Leonardi","year":"2015","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.106737_b0010","article-title":"Allergic eye disease","volume":"359","author":"Patel","year":"2017","journal-title":"BMJ"},{"issue":"1 Suppl. 1","key":"10.1016\/j.intimp.2020.106737_b0015","first-page":"49","article-title":"Allergic conjunctivitis: current concepts on pathogenesis and management","volume":"32","author":"Sacchetti","year":"2018","journal-title":"J. Biol. Regul. Homeost. Agents"},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"issue":"16","key":"10.1016\/j.intimp.2020.106737_b0025","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMoa1615975","article-title":"Tofacitinib or adalimumab versus placebo for psoriatic arthritis","volume":"377","author":"Mease","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.intimp.2020.106737_b0030","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1056\/NEJMoa1112168","article-title":"Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis","volume":"367","author":"Sandborn","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1208\/s12249-019-1377-0","article-title":"Preformulation and evaluation of tofacitinib as a therapeutic treatment for asthma","volume":"20","author":"Younis","year":"2019","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.intimp.2020.106737_b0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/jpet.115.223784","article-title":"Topically administered janus-kinase inhibitors tofacitinib and oclacitinib display impressive antipruritic and anti-inflammatory responses in a model of allergic dermatitis","volume":"354","author":"Fukuyama","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.intimp.2020.106737_b0045","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/ced.13290","article-title":"Oral tofacitinib: a promising treatment in atopic dermatitis, alopecia areata and vitiligo","volume":"42","author":"Vu","year":"2017","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.intimp.2020.106737_b0050","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exer.2013.07.019","article-title":"Allergy and allergic mediators in tears","volume":"117","author":"Leonardi","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.intimp.2020.106737_b0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.trsl.2016.02.011","article-title":"Emerging concepts: mast cell involvement in allergic diseases","volume":"174","author":"Modena","year":"2016","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.intimp.2020.106737_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2009.08.035","article-title":"Mechanisms of mast cell signaling in anaphylaxis","volume":"124","author":"Metcalfe","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2020.106737_b0065","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/gene.2010.35","article-title":"Mast cell homeostasis and the JAK-STAT pathway","volume":"11","author":"Morales","year":"2010","journal-title":"Genes Immun."},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0070","doi-asserted-by":"crossref","first-page":"C589","DOI":"10.1152\/ajpcell.00235.2017","article-title":"Interleukin-6 promotes a sustained loss of endothelial barrier function via Janus kinase-mediated STAT3 phosphorylation and de novo protein synthesis","volume":"314","author":"Alsaffar","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106737_b0075","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1182\/blood.V96.6.2172","article-title":"Role of common cytokine receptor gamma chain (gamma(c))- and Jak3-dependent signaling in the proliferation and survival of murine mast cells","volume":"96","author":"Suzuki","year":"2000","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.intimp.2020.106737_b0080","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/cea.13217","article-title":"The JAK1\/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release","volume":"48","author":"Hermans","year":"2018","journal-title":"Clin. Exp. Allergy"},{"issue":"7","key":"10.1016\/j.intimp.2020.106737_b0085","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/leu.2010.109","article-title":"Inhibition of JAK-STAT signaling by TG101348: a novel mechanism for inhibition of KITD816V-dependent growth in mast cell leukemia cells","volume":"24","author":"Lasho","year":"2010","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0090","first-page":"864","article-title":"Janex-1, a JAK3 inhibitor, ameliorates tumor necrosis factor-\u03b1-induced expression of cell adhesion molecules and improves myocardial vascular permeability in endotoxemic mice","volume":"29","author":"Lee","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0095","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41385-019-0187-8","article-title":"Short ragweed pollen promotes M2 macrophage polarization via TSLP\/TSLPR\/OX40L signaling in allergic inflammation","volume":"12","author":"Deng","year":"2019","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2020.106737_b0100","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1167\/iovs.15-17914","article-title":"Topical administration of \u03b2-1,3-glucan to modulate allergic conjunctivitis in a murine model","volume":"57","author":"Lee","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2020.106737_b0105","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1167\/iovs.08-2154","article-title":"Transcriptional analyses before and after suppression of immediate hypersensitivity reactions by CCR3 blockade in eyes with experimental allergic conjunctivitis","volume":"49","author":"Komatsu","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0110","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0091-6749(96)70268-3","article-title":"A new murine model of allergic conjunctivitis and effectiveness of nedocromil sodium","volume":"97","author":"Merayo-Lloves","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106737_b0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jaci.2014.12.1926","article-title":"Culture medium from TNF-\u03b1-stimulated mesenchymal stem cells attenuates allergic conjunctivitis through multiple antiallergic mechanisms","volume":"136","author":"Su","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106737_b0120","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jaci.2018.01.043","article-title":"Mast cell activation test in the diagnosis of allergic disease and anaphylaxis","volume":"142","author":"Bahri","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106737_b0125","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1021\/acs.biomac.0c00147","article-title":"Multifunctional dendrimer-entrapped gold nanoparticles for labeling and tracking T cells via dual-modal computed tomography and fluorescence imaging","volume":"21","author":"Chen","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.intimp.2020.106737_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2020.120731","article-title":"A sperm-cell-based biosensor using a fluorescence probe for responsive signal readout toward bitter flavor detection","volume":"211","author":"Tian","year":"2020","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0135","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cea.13590","article-title":"Pea (Pisum sativum) allergy in children: Pis s 1 is an immunodominant major pea allergen and presents IgE binding sites with potential diagnostic value","volume":"50","author":"Popp","year":"2020","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.intimp.2020.106737_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106500","article-title":"The antipsychotic drug pimozide inhibits IgE-mediated mast cell degranulation and migration","volume":"84","author":"Hou","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2020.106737_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114008","article-title":"HMF causes anaphylactic symptoms by acting as a H1 receptor agonist","volume":"177","author":"He","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106737_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2018.02.004","article-title":"Rapamycin attenuates Th2-driven experimental allergic conjunctivitis","volume":"190","author":"Shin","year":"2018","journal-title":"Clin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2020.106737_b0155","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1194\/jlr.M085233","article-title":"5,6-DiHETE attenuates vascular hyperpermeability by inhibiting Ca2+ elevation in endothelial cells","volume":"59","author":"Hamabata","year":"2018","journal-title":"J. Lipid Res."},{"issue":"10093","key":"10.1016\/j.intimp.2020.106737_b0160","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0140-6736(17)31618-5","article-title":"Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b\/4, double-blind, head-to-head, randomised controlled trial","volume":"390","author":"Fleischmann","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.intimp.2020.106737_b0165","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/imt-2018-0015","article-title":"The use of tofacitinib in the treatment of inflammatory bowel disease","volume":"10","author":"Weisshof","year":"2018","journal-title":"Immunotherapy"},{"issue":"9","key":"10.1016\/j.intimp.2020.106737_b0170","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/TP.0000000000001226","article-title":"Targeting JAK\/STAT signaling to prevent rejection after kidney transplantation: a reappraisal","volume":"100","author":"Baan","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0175","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjd.14871","article-title":"Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial","volume":"175","author":"Bissonnette","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2020.106737_b0180","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/bjd.16798","article-title":"Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study","volume":"179","author":"Valenzuela","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2020.106737_b0185","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41591-019-0733-7","article-title":"Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report","volume":"26","author":"Kim","year":"2020","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.intimp.2020.106737_b0190","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2014.08.001","article-title":"Doxycycline exerts multiple anti-allergy effects to attenuate murine allergic conjunctivitis and systemic anaphylaxis","volume":"91","author":"Su","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106737_b0195","first-page":"CD009566","article-title":"Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis","volume":"6","author":"Castillo","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2020.106737_b0200","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/ACI.0000000000000473","article-title":"Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends","volume":"18","author":"Ben-Eli","year":"2018","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.106737_b0205","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3389\/fimmu.2019.01020","article-title":"SLAP is a negative regulator of Fc\u03b5RI receptor-mediated signaling and allergic response","volume":"10","author":"Sharma","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106737_b0210","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2020.106737_b0215","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2017.11.017","article-title":"Evidence for autocrine and paracrine regulation of allergen-induced mast cell mediator release in the guinea pig airways","volume":"822","author":"Yu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2020.106737_b0220","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3389\/fimmu.2018.01873","article-title":"The role of histamine and histamine receptors in mast cell-mediated allergy and inflammation: the hunt for new therapeutic targets","volume":"9","author":"Thangam","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2020.106737_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178563","article-title":"Improved efficacy of allergen-specific immunotherapy by JAK inhibition in a murine model of allergic asthma","volume":"12","author":"Aguilar-Pimentel","year":"2017","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2020.106737_b0230","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2017.06.020","article-title":"Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice","volume":"490","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2020.106737_b0235","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1136\/annrheumdis-2013-203756","article-title":"The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells","volume":"73","author":"Kubo","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.intimp.2020.106737_b0240","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/jid.2013.476","article-title":"Reversal of CD8 T-cell-mediated mucocutaneous graft-versus-host-like disease by the JAK inhibitor tofacitinib","volume":"134","author":"Okiyama","year":"2014","journal-title":"J. Invest. Dermatol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920310869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576920310869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:50:07Z","timestamp":1778820607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576920310869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":48,"alternative-id":["S1567576920310869"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106737","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2020.106737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106737"}}